A joint US Food and Drug Administration-industry study examining the impact of radiofrequency identification systems on common implantable devices has raised concerns about electromagnetic interference1,2.
The study was conducted by FDA researchers in collaboration with major manufacturers of implantable cardioverter defibrillators and pacemakers, such as Medtronic, Boston Scientific, Biotronik, St Jude Medical and Sorin...
Please login to read the full article.
